 Talia Quandelacy
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 6 | 2022 | 546 | 2.080 |
Why?
| | Viruses | 2 | 2023 | 94 | 1.540 |
Why?
| | Zika Virus Infection | 4 | 2021 | 83 | 1.170 |
Why?
| | Epidemics | 3 | 2021 | 69 | 1.040 |
Why?
| | Zika Virus | 3 | 2021 | 59 | 0.920 |
Why?
| | Coronavirus 229E, Human | 1 | 2023 | 4 | 0.880 |
Why?
| | Coronavirus NL63, Human | 1 | 2023 | 3 | 0.880 |
Why?
| | Coronavirus OC43, Human | 1 | 2023 | 5 | 0.880 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 60 | 0.760 |
Why?
| | Coronavirus Infections | 2 | 2023 | 334 | 0.720 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 321 | 0.660 |
Why?
| | Puerto Rico | 5 | 2022 | 52 | 0.530 |
Why?
| | Influenza Vaccines | 1 | 2020 | 496 | 0.520 |
Why?
| | Seasons | 4 | 2023 | 448 | 0.420 |
Why?
| | Public Health | 2 | 2019 | 435 | 0.410 |
Why?
| | International Cooperation | 1 | 2011 | 172 | 0.370 |
Why?
| | Population Surveillance | 2 | 2020 | 392 | 0.350 |
Why?
| | Models, Statistical | 3 | 2021 | 602 | 0.310 |
Why?
| | Incidence | 4 | 2021 | 2318 | 0.300 |
Why?
| | Guidelines as Topic | 2 | 2021 | 245 | 0.250 |
Why?
| | Antibodies, Viral | 3 | 2023 | 522 | 0.230 |
Why?
| | Fever | 2 | 2021 | 280 | 0.210 |
Why?
| | Forecasting | 2 | 2021 | 332 | 0.190 |
Why?
| | Pennsylvania | 1 | 2021 | 94 | 0.190 |
Why?
| | Public Health Surveillance | 1 | 2021 | 61 | 0.180 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2020 | 37 | 0.180 |
Why?
| | Checklist | 1 | 2021 | 84 | 0.180 |
Why?
| | Spatio-Temporal Analysis | 1 | 2020 | 27 | 0.180 |
Why?
| | Humans | 17 | 2023 | 115049 | 0.180 |
Why?
| | Tropical Climate | 1 | 2020 | 17 | 0.180 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2020 | 40 | 0.180 |
Why?
| | Carrier State | 1 | 2021 | 54 | 0.180 |
Why?
| | Dengue | 1 | 2021 | 59 | 0.180 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 56 | 0.170 |
Why?
| | Models, Theoretical | 2 | 2020 | 517 | 0.170 |
Why?
| | Research Design | 2 | 2023 | 930 | 0.160 |
Why?
| | Antibody Formation | 1 | 2020 | 267 | 0.160 |
Why?
| | Databases, Factual | 2 | 2021 | 1132 | 0.160 |
Why?
| | Pandemics | 3 | 2022 | 1322 | 0.160 |
Why?
| | Global Health | 2 | 2011 | 288 | 0.160 |
Why?
| | Temperature | 1 | 2021 | 578 | 0.160 |
Why?
| | Schools | 1 | 2021 | 400 | 0.150 |
Why?
| | Child | 4 | 2023 | 18407 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 253 | 0.140 |
Why?
| | Computational Biology | 1 | 2021 | 533 | 0.140 |
Why?
| | Biomedical Research | 1 | 2021 | 585 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.130 |
Why?
| | Disease Outbreaks | 2 | 2019 | 309 | 0.120 |
Why?
| | Seroepidemiologic Studies | 2 | 2023 | 138 | 0.100 |
Why?
| | Federal Government | 1 | 2011 | 26 | 0.100 |
Why?
| | Utah | 1 | 2011 | 60 | 0.100 |
Why?
| | Government Regulation | 1 | 2011 | 46 | 0.100 |
Why?
| | World Health Organization | 1 | 2011 | 103 | 0.090 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 38 | 0.090 |
Why?
| | Communicable Diseases, Emerging | 1 | 2011 | 28 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 4904 | 0.090 |
Why?
| | Disaster Planning | 1 | 2011 | 74 | 0.090 |
Why?
| | Malaria | 1 | 2011 | 48 | 0.090 |
Why?
| | Program Development | 1 | 2011 | 346 | 0.080 |
Why?
| | Military Medicine | 1 | 2011 | 93 | 0.080 |
Why?
| | Health Policy | 1 | 2011 | 334 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1721 | 0.080 |
Why?
| | Pneumonia | 1 | 2013 | 568 | 0.080 |
Why?
| | Adult | 2 | 2023 | 30658 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2011 | 492 | 0.070 |
Why?
| | Age Factors | 1 | 2013 | 2894 | 0.070 |
Why?
| | United States | 3 | 2020 | 12227 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2799 | 0.050 |
Why?
| | Asymptomatic Infections | 1 | 2023 | 21 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 113 | 0.050 |
Why?
| | Infectious Disease Incubation Period | 1 | 2021 | 4 | 0.050 |
Why?
| | Basic Reproduction Number | 1 | 2021 | 3 | 0.050 |
Why?
| | Adolescent | 2 | 2021 | 17864 | 0.040 |
Why?
| | Linear Models | 1 | 2023 | 776 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 8642 | 0.040 |
Why?
| | Influenza A virus | 1 | 2020 | 90 | 0.040 |
Why?
| | Communicable Diseases | 1 | 2021 | 130 | 0.040 |
Why?
| | Guillain-Barre Syndrome | 1 | 2019 | 21 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 10498 | 0.040 |
Why?
| | Decision Support Techniques | 1 | 2021 | 351 | 0.040 |
Why?
| | Male | 3 | 2020 | 55735 | 0.030 |
Why?
| | Female | 3 | 2020 | 59617 | 0.030 |
Why?
| | Aged | 1 | 2013 | 19122 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2255 | 0.030 |
Why?
| | Middle Aged | 1 | 2013 | 26830 | 0.030 |
Why?
| | Arthropod Vectors | 1 | 2011 | 7 | 0.020 |
Why?
| | Zoonoses | 1 | 2011 | 21 | 0.020 |
Why?
| | Drug Resistance | 1 | 2011 | 158 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5040 | 0.020 |
Why?
| | Infant | 1 | 2021 | 7946 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9093 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2020 | 12548 | 0.010 |
Why?
| | Animals | 1 | 2011 | 31868 | 0.010 |
Why?
|
|
Quandelacy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|